GLP-1 receptor agonists like semaglutide and liraglutide, and dual GIP/GLP-1 receptor agonists like tirzepatide, slow gastric emptying, reduce appetite, and improve insulin sensitivity
Slowed gastric emptying
Muscogiuri G, et al
Red Flags to Watch For If you are taking GLP-1s, these warning signs suggest the medication may be interfering with recovery: Using medication effects as justification to eat less than planned or skip meals Feeling relief at having a medical reason not to eat Increased eating disorder thoughts about food, weight, or body image Return of any eating disorder behaviors (restriction beyond medication effects, purging, excessive exercise, body checking) Hiding eating patterns or medication use from your treatment team Rapid or excessive weight loss Increased anxiety around food or eating situations If you notice any of these, talk to your treatment team immediately
Researchers highlighted that carnitine deficiency, carnitine palmitoyl-transferase I or II deficiency, carnitine translocase deficiency (122), -oxidation defects (123), pyruvate carboxylase deficiency (124) should be screened before KD treatments